Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) prevention trial
is an important addition to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). As a
prevention trial, PREADVISE is trying to find out if taking selenium and/or Vitamin E
supplements can help to prevent memory loss and dementia such as Alzheimer's disease.
Details
Lead Sponsor:
Frederick Schmitt University of Kentucky
Collaborators:
National Cancer Institute (NCI) National Institute on Aging (NIA)
Treatments:
alpha-Tocopherol Selenium Tocopherols Tocotrienols Vitamin E Vitamins